ABACUS MEDICINE PHARMA SERVICES LTD
Get an alert when ABACUS MEDICINE PHARMA SERVICES LTD files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£0
-100% lowest in 6 filed years
Net assets
£330K
+1,153.3% highest in 6 filed years
Employees
21
-8.7% vs 2024
Profit before tax
£348K
-95.7% first positive since 2023
Net assets
6-year trend · vs Consumer Discretionary median
Accounts
6-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|---|---|---|
| Turnover | — | — | — | £30,544,908 | £20,444,641 | £6,271,904 | -69.3% | |
| Operating profit | — | — | — | -£741,958 | £8,562,865 | £761,262 | -91.1% | |
| Profit before tax | — | — | — | -£1,490,326 | £8,102,722 | £348,035 | -95.7% | |
| Net profit | -£2,287,895 | -£2,315,277 | -£1,956,682 | -£1,490,326 | £7,711,883 | £348,035 | -95.5% | |
| Cash | £3 | £168,258 | £490,346 | £3,199,453 | £4,985,263 | £0 | -100% | |
| Total assets less current liabilities | — | — | — | -£7,759,528 | -£31,326 | £329,964 | +1,153.3% | |
| Net assets | — | — | — | -£7,759,528 | -£31,326 | £329,964 | +1,153.3% | |
| Equity | -£2,026,995 | -£4,325,425 | -£6,280,620 | -£7,759,528 | -£31,326 | £329,964 | +1,153.3% | |
| Average employees | 17 | 18 | 20 | 22 | 23 | 21 | -8.7% | |
| Wages | — | — | — | £2,780,016 | £1,811,869 | £1,845,701 | +1.9% | |
| Directors' remuneration | — | — | — | £200,549 | £174,992 | £148,445 | -15.2% |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | -2.4% | 41.9% | 12.1% | |
| Net margin | — | — | — | -4.9% | 37.7% | 5.5% | |
| Return on capital employed | — | — | — | — | — | 230.7% | |
| Current ratio | — | — | — | 0.43x | 1.00x | 1.20x | |
| Interest cover | — | — | — | -0.90x | 7.95x | 1.30x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- ABACUS MEDICINE PHARMA SERVICES LTD 2022-01-05 → present
- APOSAVE LTD 2014-07-01 → 2022-01-05
- ORIGINALIS LTD 2013-12-11 → 2014-07-01
Audit & accounting basis
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- UHY Hacker Young
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.”
Significant events
- “During the prior year the company underwent a strategic transformation and transitioned to a cost-plus business model. This was part of a strategic initiative to ensure future growth and stability. As part of this transition certain commercial risks related to the Clinical Trial Services (CTS) business were transferred from the company to Abacus Medicine A/S within the group which implies a transfer of activity or on-going concern which includes decision-making functions and commercial risk.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
2 active · 4 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HAMILTON, Maxine | Director | 2024-05-01 | Feb 1970 | British |
| WAGNER, Flemming, Director | Director | 2024-04-01 | Nov 1964 | Danish |
Show 4 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ESTCOURT, Simon | Director | 2018-11-01 | 2024-03-31 |
| HAMILTON, Maxine, Mrs. | Director | 2024-05-01 | 2024-05-01 |
| WAGNER, Flemming | Director | 2017-01-18 | 2020-01-01 |
| WAGNER, John | Director | 2013-12-11 | 2017-01-18 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Flemming Wagner | Individual | Significant influence | 2020-01-01 | Active |
| Abacus Medicine Pharma Services Aps | Corporate entity | Shares 75–100%, Voting 75–100% | 2017-12-21 | Active |
| Flemming Wagner | Individual | Significant influence | 2016-04-06 | Ceased 2020-01-01 |
Filing timeline
Last 20 of 50 total filings
Material constitutional events — rename, articles re-file, resolution
- 2022-01-05 CERTNM Certificate change of name company PDF
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-06-24 | AA | accounts | Accounts with accounts type full | |
| 2026-01-07 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-12-22 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-17 | TM01 | officers | Termination director company with name termination date | |
| 2025-07-01 | AA | accounts | Accounts with accounts type full | |
| 2025-01-21 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-06-11 | AA | accounts | Accounts with accounts type small | |
| 2024-05-01 | AP01 | officers | Appoint person director company with name date | |
| 2024-05-01 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-04-05 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-02 | TM01 | officers | Termination director company with name termination date | |
| 2023-12-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-06-08 | AA | accounts | Accounts with accounts type small | |
| 2023-01-17 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-28 | AA | accounts | Accounts with accounts type small | |
| 2022-01-05 | CERTNM | change-of-name | Certificate change of name company | |
| 2022-01-04 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-12-22 | AA | accounts | Accounts with accounts type small | |
| 2021-12-20 | PSC01 | persons-with-significant-control | Notification of a person with significant control | |
| 2021-12-16 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 5
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.